Related Experiment Video
Updated: Aug 8, 2026

14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Computational Strategies for Discovering Inhibitors Targeting Therapeutic Enzymes
1Department of Biotechnology Engineering, Institute of Engineering and Technology, Bundelkhand University, Jhansi, UP, India. pandayanandkumar@gmail.com.
Methods in Molecular Biology (Clifton, N.J.)
|August 7, 2026
Summary
Computational drug discovery accelerates finding new medicines. This guide combines structure-based and ligand-based methods for identifying drug inhibitors, reducing costs and time.
Area of Science:
- Computational chemistry
- Drug discovery
- Medicinal chemistry
Background:
- Computational strategies significantly accelerate drug discovery.
- Algorithms exist for target identification through to hit molecule discovery.
- These methods reduce cost and time while improving prediction accuracy.
Purpose of the Study:
- To provide a comprehensive procedure for discovering drug inhibitors.
- To combine structure-based and ligand-based computational approaches.
- To guide the use of computational platforms for successful drug discovery.
Main Methods:
- Target identification via comparative genomics and network-based approaches.
- AI-based molecular modeling and ligand-based pharmacophore modeling.
- Structure-based molecular docking, virtual screening, molecular dynamics, and free energy calculations.
Main Results:
- The discussed methods enable efficient identification of potential drug targets.
- Virtual screening of large compound libraries can be performed effectively.
- Accurate prediction of drug-target interactions and inhibitor efficacy is enhanced.
Conclusions:
- This work serves as a guide for employing computational platforms in drug discovery.
- Combining diverse computational methods optimizes the inhibitor discovery process.
- Successful drug discovery relies on the effective utilization of advanced computational tools.
Keywords:
Drug target identificationEnd-state free energy analysisMolecular dynamics simulationPharmacophore modelingVirtual screening and molecular dockingMore Related Videos
Related Concept Videos
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

